About the Guest: Dr. Berra Yazar-Klosinski, the Chief Science Officer for the Multidisciplinary Association for Psychedelic Studies (MAPS).
Episode Summary: Nick Jikomes and Berra Yazar-Klosinski, PhD talked about the results of MAPS' recent Phase III clinical trials for treating severe PTSD, how these studies are conducted, and what we know about the underlying biology of Post-Traumatic Stress Disorder (PTSD) and the drug MDMA (also known as 'ecstasy.'
Relevant Links:
Audio sound clip:
Comments